A phase 3, randomized, open-label, multicentre study to evaluate the efficacy and safety of diltiazem plus lidocaine fixed-dose combination gel versus diltiazem gel in Indian patients with anal fissure

Kushal Mital; Naga Babu; Apoorva Patel; R. K. Jauhari; Sanjeev Mohan; Indraneel Basu; Shivani Acharya; Rajan Verma; Jejoe Karankumar

doi:10.18203/2320-6012.ijrms20254384

Authors

Kushal Mital Medicare Hospital, Silver Plaza, Ramchandra Nagar, Thane, Maharashtra, India
Naga Babu Department of Surgery, King George Hospital, Maharanipeta, Visakhapatnam, Andhra Pradesh, India
Apoorva Patel Shree Vrajesh Surgical Hospital, Bodakdev, Ahmedabad, Gujarat, India
R. K. Jauhari Department of Surgery, GSVM Medical College, Swaroop Nagar, Kanpur, Uttar Pradesh, India
Sanjeev Mohan Atharva Multispecialty Hospital and Research Center, Avas Vikas Parishad, Lucknow, Uttar Pradesh, India
Indraneel Basu Popular Hospital, Kakarmatta, Varanasi, Uttar Pradesh, India
Shivani Acharya Abbott R & D centre, Marol MIDC Industry Estate, Andheri East, Mumbai, Maharashtra, India
Rajan Verma Abbott R & D centre, Marol MIDC Industry Estate, Andheri East, Mumbai, Maharashtra, India
Jejoe Karankumar Abbott India Limited, Bandra (E) Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20254384

Keywords:

Anal fissures, Diltiazem, Fixed-dose combination, Lidocaine, Pain relief

Abstract

Background: Anal fissures cause significant pain and morbidity, requiring prompt and effective treatment. This study aims to evaluate the efficacy and safety of a fixed-dose combination (FDC) gel containing diltiazem and lidocaine compared to diltiazem gel alone in the treatment of anal fissures.

Methods: In this randomized, open-label, phase 3 study, eligible Indian patients (n=326) of either sex, aged 18 to 64 years, were randomly allocated (1:1) to the test (FDC diltiazem and lidocaine) or reference (diltiazem) group. Patients were asked to apply ~1 g of test or reference product, intra-anally, thrice-a-day, for 40±2 days. The assessment time points were day 1, 5, 10, 25, and 40.

Results: There was a significant reduction in pain scores between the test group and the reference group at the assessment time points. The least-squares mean difference in the mean anal pain intensity reduction from Baseline to day 10 between test and reference groups was ─.1 (95% confidence interval: ─9.18, ─3.02; p=0.0001). More patients in the test versus reference group had pain relief at 0.5 hours after first treatment application on day 1 (60.7% versus 48.8%; p=0.0302). Proportion of patients with partial healing of anal fissure was significantly higher at day 5 (64.2% versus 46.5%; p=0.0015) and day 10 (92.5% versus 81.5%; p=0.0036) in the test versus reference group) treatment-emergent adverse events occurred in four patients in the test group and in eight patients in the reference group.

Conclusions: In this large, phase 3 multicentric study, the FDC of diltiazem and lidocaine demonstrated superior pain intensity reduction and early onset of pain relief with an acceptable safety profile as compared with diltiazem gel alone in Indian patients with anal fissure.

Metrics

Metrics Loading ...

References

Jonas M, Scholefield JH. Anal Fissure. Gastroenterol Clin North Am. 2001:30(1):167-81. DOI: https://doi.org/10.1016/S0889-8553(05)70172-2

Beaty JS, Shashidharan M, Anal Fissure. Clin Colon Rectal Surg. 2016;29(1):30-7. DOI: https://doi.org/10.1055/s-0035-1570390

Wienert V, Raulf F, Mlitz H. Anal fissure disease: Prevention and quality of life. In: Wienert V, Raulf F, Mlitz H, editors. Anal Fissure. Springer: Cham, Switzerland. 2017:55-65. DOI: https://doi.org/10.1007/978-3-319-49244-5_5

Stewart DB Sr, Gaertner W, Glasgow S, Migaly J, Feingold D, Steele SR. Clinical practice guideline for the management of anal fissures. Dis Colon Rectum. 2017;60(1):7-14. DOI: https://doi.org/10.1097/DCR.0000000000000735

Higuero T. Update on the management of anal fissure. J Visc Surg. 2015;152:S37-43. DOI: https://doi.org/10.1016/j.jviscsurg.2014.07.007

Khan RM, Itrat M, Ansari AH, Ahmer SM, Zulkifle. Prevalence of fissure-in-ano among the patients of anorectal complaints visiting Nium hospital. J Commun Med Health Edu. 2015;5(2):344.

Sharma R, Kaur A, Mittal S, Goyal R, Neki NS. Clinical study of perianal disorders and their management: A study of 200 cases. Int J Med Health Res, 2017;3(3):3-5.

Varsha SB, Jagadish H. Nitroglycerine: A paradigm in treatment of chronic anal fissure. Med J Clin Trials Case Stud. 2017;1(1):000102. DOI: https://doi.org/10.23880/MJCCS-16000102

Varadarajan MS, Sony PS, Anandan H. Prevalence and clinical presentation of fissure-in-ano in a tertiary care centre. Int J Sci Stud. 2018;5(12):70-2.

Chaudhary R, Dausage CS. Prevalence of anal fissure in patients with anorectal disorders: a single-centre experience. J Clin Diagn Res. 2019:13(2):PC05-7. DOI: https://doi.org/10.7860/JCDR/2019/38478.12563

Kujur ADS, Paul Ekka NM, Chandra S, Lal S, Malua S, Comparative study to assess the effectiveness of topical nifedipine and diltiazem in the treatment of chronic anal fissure. J Family Med Prim Care. 2020;9(11):5652-57. DOI: https://doi.org/10.4103/jfmpc.jfmpc_986_20

Nothmann BJ, Schuster MM. Internal anal sphincter derangement with anal fissures. Gastroenterology. 1974;67(2):216-20. DOI: https://doi.org/10.1016/S0016-5085(19)32882-3

Griffin N, Acheson AG, Tung P, Sheard C, Glazebrook C, Scholefield JH. Quality of life in patients with chronic anal fissure. Colorectal Dis. 2004;6(1):39-44. DOI: https://doi.org/10.1111/j.1463-1318.2004.00576.x

Tsunoda A, Kashiwagura Y, Hirose K, Sasaki T, Kano N. Quality of life in patients with chronic anal fissure after topical treatment with diltiazem. World J Gastrointest Surg. 2012;4(11):251-5. DOI: https://doi.org/10.4240/wjgs.v4.i11.251

Altomare DF, Binda GA, Canuti S, Landolfi V, Trompetto M, Villani RD. The management of patients with primary chronic anal fissure: a position paper. Tech Coloproctol. 2011;15(2):135-41. DOI: https://doi.org/10.1007/s10151-011-0683-7

Haq Z, Rahman M, Chowdhury RA, Baten MA, Khatun M. Chemical sphincterotomy--first line of treatment for chronic anal fissure. Mymensingh Med J. 2005;14(2):88-90.

Farooq U, Farooq S, Zahir S, Chaudhry AM. Comparison of surgical and chemical sphincterotomy in the management of acute anal fissures. Pak J Med Health Sci. 2012;6(1):24-31.

Mital K, Maroo SK, Patel K, Ojha R. Topical diltiazem alone versus diltiazem with lidocaine for the treatment of chronic anal fissure: a prospective, randomized controlled clinical trial. Am J Pharm Tech Res. 2013;3(6):185-92.

Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120(8):713-9. DOI: https://doi.org/10.1016/j.amjmed.2006.08.033

Salem AE, Mohamed EA, Elghadban HM, Abdelghani GM. Potential combination topical therapy of anal fissure: development, evaluation, and clinical study. Drug Deliv. 2018;25(1):1672-82. DOI: https://doi.org/10.1080/10717544.2018.1507059

Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010;162(3):587-93. DOI: https://doi.org/10.1111/j.1365-2133.2009.09586.x

Hang MTH, Smith BE, Keck C, Keshavarzian A, Sedghi S. Increasing efficacy and reducing side effects in treatment of chronic anal fissures: A study of topical diazepam therapy. Medicine (Baltimore). 2017;96(20):e6853. DOI: https://doi.org/10.1097/MD.0000000000006853

Sahebally SM, Ahmed K, Cerneveciute R, Iqbal A, Walsh SR, Joyce MR. Oral versus topical calcium channel blockers for chronic anal fissure-a systematic review and meta-analysis of randomized controlled trials. Int J Surg. 2017;44:87-93. DOI: https://doi.org/10.1016/j.ijsu.2017.06.039

Sajid MS, Whitehouse PA, Sains P, Baig MK. Systematic review of the use of topical diltiazem compared with glyceryltrinitrate for the nonoperative management of chronic anal fissure. Colorectal Dis. 2013;15(1):19-26. DOI: https://doi.org/10.1111/j.1463-1318.2012.03042.x

Gopivallabh MM, Puranik G. Chemical sphincterotomy with topical 2% diltiazem for chronic anal fissure: Our experience. Int J Res Health Sci. 2014;2(3):806-11.

Pardhan A, Azami R, Mazahir S, Murtaza G. Diltiazem vs. glyceryl tri-nitrate for symptomatic relief in anal fissure: a randomised clinical study. J Pak Med Assoc .2014;64(5):510-3.

Lu Y, Kwaan MR, Lin AY. Diagnosis and treatment of anal fissures in 2021. JAMA. 2021;325(7):688-9. DOI: https://doi.org/10.1001/jama.2020.16705

Xylocaine ointment 5% prescribing information. 2006. Available at https://pdf.hres.ca/dpd_pm/ 00003402.PDF. Accessed on 03 August 2025.

Zimmermann J, Schlegelmilch R, Mazur D, Seiler D, Vens-Cappell B. Proof of systemic safety of a lidocaine ointment in the treatment of patients with anorectal pain. Arzneimittelforschung. 2007;57(1):12-9. DOI: https://doi.org/10.1055/s-0031-1296580

Perrotti P, Bove A, Antropoli C, Molino D, Antropoli M, Balzano A, et al. Topical nifedipine with lidocaine ointment vs. active control for treatment of chronic anal fissure: results of a prospective, randomized, double-blind study. Dis Colon Rectum. 2002;45(11):1468-75. DOI: https://doi.org/10.1007/s10350-004-6452-1